Overview
The Food and Drug Administration is the federal agency responsible for regulating drugs, medical devices, food safety, and biological products. It approves new drugs, monitors drug safety, and oversees pharmaceutical manufacturing — but does not control production volumes, creating a regulatory gap with the DEA on controlled substances.
Key Facts
- Part of the Department of Health and Human Services
- Approves drugs for market but does not set production quotas for controlled substances (that authority lies with the Drug Enforcement Administration)
- Regulates the safety and efficacy of over-the-counter and prescription medications
Newsletter Relevance
The FDA’s regulatory authority intersects with critical infrastructure questions: who controls pharmaceutical supply chains, how regulatory fragmentation creates chokepoints, and how agency jurisdiction gaps (FDA handles safety, DEA handles supply) produce systemic failures like the ADHD Medication Shortage.
Connections
- ADHD Medication Shortage — FDA’s drug approval authority intersects with DEA quota-setting to shape stimulant availability
- Drug Enforcement Administration — overlapping jurisdiction on controlled substances creates policy friction
Source Appearances
- Trump Nominates Erica Schwartz as CDC Director — FDA’s Sara Brenner named CDC senior counselor for public health in April 2026 reshuffle
Open Questions
- How has the FDA responded to medication shortages caused by DEA production quotas?
- What regulatory reforms have been proposed to bridge the FDA-DEA jurisdiction gap on controlled substances?